HOUSTON — A new study offers a possible biological explanation for the forgetfulness many people report during pregnancy, linking sustained high estrogen to a pathway between the hypothalamus and hippocampus.
Researchers reported in Science Bulletin that elevated estrogen overactivated inhibitory GABA-producing neurons in the hypothalamus of mice. Those signals reduced activity in the hippocampus, a region central to memory. When the team switched off the pathway or removed estrogen receptors from the relevant neurons, the animals’ memory performance recovered; activating the pathway produced impairment even without extra estrogen.
The experiments establish a causal mechanism in mice, not in pregnant women. That boundary is essential. Animal models allow researchers to manipulate cells and circuits in ways that would be unsafe and unethical in people.
To test whether the broader pattern might translate, the researchers also assessed 70 women at different stages of pregnancy and outside pregnancy. Memory changes appeared most clearly late in pregnancy and were associated with higher circulating estrogen, according to Reuters. The human results are consistent with the proposed pathway, but they do not prove that it caused the changes.
About 80% of pregnant women report some form of “pregnancy brain,” the researchers said, although that estimate is largely based on subjective accounts. Typical experiences include misplacing objects, forgetting an intended task or losing the thread of a conversation. The study does not suggest a general loss of intelligence, and symptoms are usually temporary.
Other factors can affect concentration and recall during pregnancy, including interrupted sleep, nausea, pain, stress, depression, anaemia and the practical load of preparing for a baby. A biological explanation should not be used to dismiss those conditions or to tell women that every cognitive concern is normal.
The work does not create a treatment. Manipulating estrogen or inhibitory brain signalling during pregnancy could carry serious risks, and no one should change medication on the basis of a mouse study. Persistent confusion, neurological symptoms or a sudden loss of function requires clinical assessment.
The study’s immediate value is recognition. Pregnancy-related forgetfulness can be specific, measurable and temporary without defining a person’s competence. Better research now needs larger and more diverse human cohorts, postpartum follow-up and careful separation of hormone effects from sleep, mood and social stress.
Join the discussion